Next Article in Journal
A Multidisciplinary Approach to the Management of Eales Disease: A Case Report and Review of the Literature
Previous Article in Journal
Personalized Medicine Transformed: ChatGPT’s Contribution to Continuous Renal Replacement Therapy Alarm Management in Intensive Care Units
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Foss et al. The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation. J. Pers. Med. 2022, 12, 692

by
Kimberly S. Foss
1,*,
Julianne M. O’Daniel
1,
Jonathan S. Berg
1,
Sabrina N. Powell
1,
Rosemary Jean Cadigan
2,
Kristine J. Kuczynski
2,
Laura V. Milko
1,
Katherine W. Saylor
3,
Megan Roberts
4,
Karen Weck
1,5 and
Gail E. Henderson
2
1
Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA
2
Department of Social Medicine, University of North Carolina, Chapel Hill, NC 27599, USA
3
Department of Public Policy, University of North Carolina, Chapel Hill, NC 27599, USA
4
Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA
5
Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2024, 14(3), 234; https://doi.org/10.3390/jpm14030234
Submission received: 29 January 2024 / Accepted: 30 January 2024 / Published: 22 February 2024
(This article belongs to the Section Pharmacogenetics)

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

There was an error in the original publication [...]

Share and Cite

MDPI and ACS Style

Foss, K.S.; O’Daniel, J.M.; Berg, J.S.; Powell, S.N.; Cadigan, R.J.; Kuczynski, K.J.; Milko, L.V.; Saylor, K.W.; Roberts, M.; Weck, K.; et al. Correction: Foss et al. The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation. J. Pers. Med. 2022, 12, 692. J. Pers. Med. 2024, 14, 234. https://doi.org/10.3390/jpm14030234

AMA Style

Foss KS, O’Daniel JM, Berg JS, Powell SN, Cadigan RJ, Kuczynski KJ, Milko LV, Saylor KW, Roberts M, Weck K, et al. Correction: Foss et al. The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation. J. Pers. Med. 2022, 12, 692. Journal of Personalized Medicine. 2024; 14(3):234. https://doi.org/10.3390/jpm14030234

Chicago/Turabian Style

Foss, Kimberly S., Julianne M. O’Daniel, Jonathan S. Berg, Sabrina N. Powell, Rosemary Jean Cadigan, Kristine J. Kuczynski, Laura V. Milko, Katherine W. Saylor, Megan Roberts, Karen Weck, and et al. 2024. "Correction: Foss et al. The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation. J. Pers. Med. 2022, 12, 692" Journal of Personalized Medicine 14, no. 3: 234. https://doi.org/10.3390/jpm14030234

APA Style

Foss, K. S., O’Daniel, J. M., Berg, J. S., Powell, S. N., Cadigan, R. J., Kuczynski, K. J., Milko, L. V., Saylor, K. W., Roberts, M., Weck, K., & Henderson, G. E. (2024). Correction: Foss et al. The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation. J. Pers. Med. 2022, 12, 692. Journal of Personalized Medicine, 14(3), 234. https://doi.org/10.3390/jpm14030234

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop